FDA Approves Combination Drug for Patients with Advanced Colorectal Cancer



The FDA has approved a single drug that combines trifluridine and tipiracil to treat patients with metastatic colorectal cancer whose disease progressed after standard treatment.



Source link

Comments are closed.